Selected research
Industry Research
Sheep and Goat Pox Vaccines Industry Research Report 2026
Market perspective
The global Sheep and Goat Pox Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sheep and Goat Pox Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sheep and Goat Pox Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sheep and Goat Pox Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sheep and Goat Pox Vaccines include Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd. and JOVAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sheep and Goat Pox Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sheep and Goat Pox Vaccines Market by Company
Agrovet
Biopharma
Dollvet
FGBI - Federal Centre for Animal Health
Hester Biosciences Limited
Indian Immunologicals Limited
Institut Pasteur d'Algerie
Intervac (PVT) Ltd.
JOVAC
Vetal Company
Veterinary Research Institute
Tiankang Biopharmacuetical
Sheep and Goat Pox Vaccines Segment by Type
Attenuated Live Vaccines
Killed Vaccines
Sheep and Goat Pox Vaccines Segment by Application
Sheep
Goat
Sheep and Goat Pox Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sheep and Goat Pox Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sheep and Goat Pox Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sheep and Goat Pox Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sheep and Goat Pox Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sheep and Goat Pox Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sheep and Goat Pox Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Attenuated Live Vaccines
- Killed Vaccines
Applications
- Sheep
- Goat
Companies covered
- Agrovet
- Biopharma
- Dollvet
- FGBI - Federal Centre for Animal Health
- Hester Biosciences Limited
- Indian Immunologicals Limited
- Institut Pasteur d'Algerie
- Intervac (PVT) Ltd.
- JOVAC
- Vetal Company
- Veterinary Research Institute
- Tiankang Biopharmacuetical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sheep and Goat Pox Vaccines Market Size (2021-2032)
- 2.2.2 Global Sheep and Goat Pox Vaccines Sales (2021-2032)
- 2.2.3 Global Sheep and Goat Pox Vaccines Market Average Price (2021-2032)
- 2.3 Sheep and Goat Pox Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Attenuated Live Vaccines
- 2.3.3 Killed Vaccines
- 2.4 Sheep and Goat Pox Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Sheep
- 2.4.3 Goat
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sheep and Goat Pox Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sheep and Goat Pox Vaccines Sales (m units) of Manufacturers (2021-2026)
- 3.3 Global Sheep and Goat Pox Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Sheep and Goat Pox Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Sheep and Goat Pox Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sheep and Goat Pox Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sheep and Goat Pox Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Sheep and Goat Pox Vaccines, Established Date
- 3.9 Global Sheep and Goat Pox Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Agrovet
- 4.1.1 Agrovet Company Information
- 4.1.2 Agrovet Business Overview
- 4.1.3 Agrovet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Agrovet Sheep and Goat Pox Vaccines Product Portfolio
- 4.1.5 Agrovet Recent Developments
- 4.2 Biopharma
- 4.2.1 Biopharma Company Information
- 4.2.2 Biopharma Business Overview
- 4.2.3 Biopharma Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Biopharma Sheep and Goat Pox Vaccines Product Portfolio
- 4.2.5 Biopharma Recent Developments
- 4.3 Dollvet
- 4.3.1 Dollvet Company Information
- 4.3.2 Dollvet Business Overview
- 4.3.3 Dollvet Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dollvet Sheep and Goat Pox Vaccines Product Portfolio
- 4.3.5 Dollvet Recent Developments
- 4.4 FGBI - Federal Centre for Animal Health
- 4.4.1 FGBI - Federal Centre for Animal Health Company Information
- 4.4.2 FGBI - Federal Centre for Animal Health Business Overview
- 4.4.3 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Portfolio
- 4.4.5 FGBI - Federal Centre for Animal Health Recent Developments
- 4.5 Hester Biosciences Limited
- 4.5.1 Hester Biosciences Limited Company Information
- 4.5.2 Hester Biosciences Limited Business Overview
- 4.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Portfolio
- 4.5.5 Hester Biosciences Limited Recent Developments
- 4.6 Indian Immunologicals Limited
- 4.6.1 Indian Immunologicals Limited Company Information
- 4.6.2 Indian Immunologicals Limited Business Overview
- 4.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Portfolio
- 4.6.5 Indian Immunologicals Limited Recent Developments
- 4.7 Institut Pasteur d'Algerie
- 4.7.1 Institut Pasteur d'Algerie Company Information
- 4.7.2 Institut Pasteur d'Algerie Business Overview
- 4.7.3 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Portfolio
- 4.7.5 Institut Pasteur d'Algerie Recent Developments
- 4.8 Intervac (PVT) Ltd.
- 4.8.1 Intervac (PVT) Ltd. Company Information
- 4.8.2 Intervac (PVT) Ltd. Business Overview
- 4.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Portfolio
- 4.8.5 Intervac (PVT) Ltd. Recent Developments
- 4.9 JOVAC
- 4.9.1 JOVAC Company Information
- 4.9.2 JOVAC Business Overview
- 4.9.3 JOVAC Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 JOVAC Sheep and Goat Pox Vaccines Product Portfolio
- 4.9.5 JOVAC Recent Developments
- 4.10 Vetal Company
- 4.10.1 Vetal Company Company Information
- 4.10.2 Vetal Company Business Overview
- 4.10.3 Vetal Company Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Vetal Company Sheep and Goat Pox Vaccines Product Portfolio
- 4.10.5 Vetal Company Recent Developments
- 4.11 Veterinary Research Institute
- 4.11.1 Veterinary Research Institute Company Information
- 4.11.2 Veterinary Research Institute Business Overview
- 4.11.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Veterinary Research Institute Sheep and Goat Pox Vaccines Product Portfolio
- 4.11.5 Veterinary Research Institute Recent Developments
- 4.12 Tiankang Biopharmacuetical
- 4.12.1 Tiankang Biopharmacuetical Company Information
- 4.12.2 Tiankang Biopharmacuetical Business Overview
- 4.12.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Portfolio
- 4.12.5 Tiankang Biopharmacuetical Recent Developments
5 Global Sheep and Goat Pox Vaccines Market Scenario by Region
- 5.1 Global Sheep and Goat Pox Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sheep and Goat Pox Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Sheep and Goat Pox Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Sheep and Goat Pox Vaccines Sales by Region: 2027-2032
- 5.3 Global Sheep and Goat Pox Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Sheep and Goat Pox Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Sheep and Goat Pox Vaccines Revenue by Region: 2027-2032
- 5.4 North America Sheep and Goat Pox Vaccines Market Facts & Figures by Country
- 5.4.1 North America Sheep and Goat Pox Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Sheep and Goat Pox Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sheep and Goat Pox Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Sheep and Goat Pox Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Sheep and Goat Pox Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sheep and Goat Pox Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sheep and Goat Pox Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sheep and Goat Pox Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sheep and Goat Pox Vaccines Market Facts & Figures by Country
- 5.7.1 South America Sheep and Goat Pox Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Sheep and Goat Pox Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sheep and Goat Pox Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sheep and Goat Pox Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sheep and Goat Pox Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sheep and Goat Pox Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sheep and Goat Pox Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Sheep and Goat Pox Vaccines Sales by Type (2021-2032) & (m units)
- 6.1.2 Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Sheep and Goat Pox Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Sheep and Goat Pox Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Sheep and Goat Pox Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sheep and Goat Pox Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Sheep and Goat Pox Vaccines Sales by Application (2021-2032) & (m units)
- 7.1.2 Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Sheep and Goat Pox Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Sheep and Goat Pox Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Sheep and Goat Pox Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sheep and Goat Pox Vaccines Value Chain Analysis
- 8.1.1 Sheep and Goat Pox Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sheep and Goat Pox Vaccines Production Mode & Process
- 8.2 Sheep and Goat Pox Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sheep and Goat Pox Vaccines Distributors
- 8.2.3 Sheep and Goat Pox Vaccines Customers
9 Global Sheep and Goat Pox Vaccines Analyzing Market Dynamics
- 9.1 Sheep and Goat Pox Vaccines Industry Trends
- 9.2 Sheep and Goat Pox Vaccines Industry Drivers
- 9.3 Sheep and Goat Pox Vaccines Industry Opportunities and Challenges
- 9.4 Sheep and Goat Pox Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst